OIG & Compliance
Expert articles and analysis related to oig & compliance.
AI Summary â Last 30 Days
In the past 30 days, significant changes in compliance and risk management for Medicare Advantage have emerged, highlighted by Aetna's settlement of $117.7 million for upcoding allegations, reflecting ongoing tensions surrounding compliance with the False Claims Act that could impact payer strategies and future reimbursement models. Meanwhile, HHS Secretary Robert F. Kennedy Jr. and CMS Administrator Dr. Mehmet Oz have ramped up scrutiny on Medicaid fraud, targeting noncompliance at the state level, which may shape how ACOs address population health management and funding in light of evolving Medicaid policies. The new emphasis on compliance audits and enforcement could foster a more accountable landscape for value-based care as stakeholders adapt to heightened regulatory expectations, particularly regarding chronic care management and diagnosis coding accuracy, as evidenced by recent audits from the Office of Inspector General.
Related Articles
Attorney General Jeff Jackson Announces $12.7 Million Medicaid Fraud Sentencings - Office of Inspector General (.gov)
Attorney General Jeff Jackson Announces $12.7 Million Medicaid Fraud Sentencings  Office of Inspector General (.gov)
10 Medicaid Providers Facing Fraud Charges - Office of Inspector General (.gov)
10 Medicaid Providers Facing Fraud Charges  Office of Inspector General (.gov)
Arizona Cardiology Group to Pay $4.75M to Resolve Allegations of Unnecessary Vein Ablations - Office of Inspector General (.gov)
Arizona Cardiology Group to Pay $4.75M to Resolve Allegations of Unnecessary Vein Ablations  Office of Inspector General (.gov)
ldyrda@beckershealthcare.com
From newsletter: ASCs' financial 'farm mentality' | Erlanger's Stark law cases advance | 4 DME fraud cases | ASC development site for surgeons debuts | Wis. system to close physician clinic ASC fi...
Final Rule: Revisions and Technical Corrections to 42 CFR Chapter V - Office of Inspector General (.gov)
Final Rule: Revisions and Technical Corrections to 42 CFR Chapter VÂ Â Office of Inspector General (.gov)
cmpfinal.pdf - OIG - Office of Inspector General (.gov)
cmpfinal.pdf - OIGÂ Â Office of Inspector General (.gov)
A-07-22-01207_highlights.pdf - Office of Inspector General (.gov)
A-07-22-01207_highlights.pdf  Office of Inspector General (.gov)
A-07-22-01207.pdf - Office of Inspector General (.gov)
A-07-22-01207.pdf  Office of Inspector General (.gov)
fr-79-91.pdf - Office of Inspector General (.gov)
fr-79-91.pdf  Office of Inspector General (.gov)
Legal Perspective: Navigating Fraud & Abuse Risk in Medical Device Pricing and Discounting Strategies
Legal Perspective: Navigating Fraud & Abuse Risk in Medical Device Pricing and Discounting Strategies  Bass, Berry & Sims PLC